SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-037044
Filing Date
2023-07-31
Accepted
2023-07-31 16:30:30
Documents
4
Period of Report
2023-09-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20009274x1_def14a.htm DEF 14A 796348
2 logo_roivant02x1.jpg GRAPHIC 34616
3 ny20009274x1-pc_1.jpg GRAPHIC 656031
4 ny20009274x1-pc_2.jpg GRAPHIC 529120
  Complete submission text file 0001140361-23-037044.txt   2476411
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-40782 | Film No.: 231127751
SIC: 2834 Pharmaceutical Preparations